OncoImmunology
Volume 10, 2021 - Issue 1
Open access
2,461
Views
2
CrossRef citations to date
0
Altmetric
Research Article
CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation
Ryan M Reyesa South Texas Medical Scientist Training Program, University of Texas Health San Antonio, San Antonio, TX, USA;b Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
, Chenghao Zhangb Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA;c Xiangya Medical School, Central South University, Changsha, Hunan, ChinaView further author information
, Yilun Dengb Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
, Niannian Jid Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
, Neelam Mukherjeed Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
, Alvaro S Padrone Division of Hematology/Oncology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
, Curtis A Clarkb Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
, Robert S Svatekb Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA;d Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USAView further author information
& Tyler J Curielb Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX, USA;e Division of Hematology/Oncology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USACorrespondence[email protected]
View further author information
show allView further author information
Article: 2006529
|
Received 24 Jul 2021, Accepted 09 Nov 2021, Published online: 22 Nov 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.